News headlines applaud weight loss medications that give the BIGGEST or FASTEST weight loss. But is greater or faster weight loss actually better? Learn more: https://drsue.ca/2025/11/headlines-is-faster-and-greater-weight-loss-a-good-thing/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you ha...

Some people don't tolerate GLP-1 medications, or need something more for weight loss. Could amylin agonists be the next hormone-based weight loss medications that could fill these gaps? Learn more: https://drsue.ca/2025/11/amylin-the-next-hormone-based-weight-management-medications/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patient...

Did you know that women with polycystic ovary syndrome, as well as women in perimenopause or menopause, are at increased risk of MASLD/MASH (formerly known as fatty liver disease)? Find out more here! Learn more: https://drsue.ca/2025/11/what-women-need-to-know-polycystic-ovary-syndrome-perimenopause-and-masld-mash-fatty-liver/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give ...

Why are people with obesity denied joint replacement surgery - and what is being done to fix it? Way to go Obesity Canada! Learn more: https://drsue.ca/2025/10/why-people-with-obesity-are-denied-joint-replacement-surgery-and-what-is-being-done-to-fix-it/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If...

Online websites that prescribe weight management medication are becoming increasingly accessible and popular. Here are some of the checkpoints to make sure you are getting the care you need and deserve. Learn more: https://drsue.ca/2025/10/online-weight-loss-medication-are-you-getting-the-treatment-you-need/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medic...

Can GLP-1 medications cause altered skin sensations? Find out what we know here. Learn more: https://drsue.ca/2025/10/can-glp-1-medications-cause-funky-skin-sensations-dysesthesia/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice spe...

Obesity expert groups around the world have created guidance documents to reframe the diagnosis and assessment of obesity, to look beyond BMI, and embracing weight-related health issues, which differ in their approaches. Today I'm talking about how we can distill these down into one very simple, easy to follow approach in clinical practice! Learn more: https://drsue.ca/2025/10/wading-through-all-the-ways-to-diagnose-obesity-can-we-find-our-way-to-a-simple-common-ground/ Any medical discussion...

Improving quality of life is a central goal in successful weight management. Do weight loss medications improve quality of life? Are there situations where quality of life could get worse, rather than better? Learn more: https://drsue.ca/2025/09/do-weight-management-medications-improve-quality-of-life/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical adv...

While we now have several injectable GLP-1s based treatments for weight management around the world [liraglutide (Saxenda), semaglutide (Wegovy), tirzepatide (Zepbound/Mounjaro)], there are no GLP-1s currently available in a pill format for obesity treatment. But that is likely soon to change, backed by a whirlwind of data that have come out around orforglipron and oral semaglutide this week. What will this mean for people seeking weight management treatment? Learn more: https://drsue.ca/2025...

Two out of three people with type 2 diabetes have 'fatty liver disease' (now called MASH/MASLD). Should everyone with prediabetes or type 2 diabetes be screened? Find out what the brand new Diabetes Canada Guidelines say here! Learn more: https://drsue.ca/2025/09/does-everyone-with-type-2-diabetes-need-to-be-screened-for-mash-masld-fatty-liver-what-the-new-diabetes-canada-guidelines-recommend/ Any medical discussion on this podcast is intended to be of a general nature only, and is inte...

Metformin has lots of benefits, including a reduction in inflammation. Is the reduction in inflammation enough to reduce pain in knee osteoarthritis? Learn more: https://drsue.ca/2025/09/could-metformin-improve-knee-osteoarthritis-pain/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a ...

Can semaglutide (Wegovy), tirzepatide (Mounjaro/Zepbound), or liraglutide (Saxenda) benefit liver health - and what did we recommend in our new 2025 Obesity Canada Pharmacotherapy Clinical Practice Guidelines? Find out here! Learn more: https://drsue.ca/2025/08/do-glp1-based-weight-management-medications-benefit-liver-health/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific...

Some people on weight management medication may want to stop treatment because of cost, or perhaps because they want to again try 'doing it on their own'. What do our new Obesity Canada 2025 Clinical Practice Guidelines recommend on this topic? Learn more: https://drsue.ca/2025/08/what-happens-if-you-stop-weight-management-medication-and-what-do-our-new-obesity-canada-guidelines-advise/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Ca...

As the lead author, I am thrilled to ANNOUNCE publication of our long-awaited 2025 Obesity Canada Clinical Practice Guidelines! Includes 13 recommendations, a brand new Decision Tool&Table to guide in the choice of medication, Key Messages for Health Care Professionals and Key Messages for People With Obesity. ENJOY!! Learn more: https://drsue.ca/2025/08/obesity-canada-pharmacotherapy-clinical-practice-guidelines-2025-published/ Any medical discussion on this podcast is intend...

In our NEW 2025 Obesity Canada Pharmacotherapy Clinical Practice Guidelines, we identified many existing gaps where data is lacking. Where did our Guidelines leave us wanting for more? Where is more research needed? Find out here! Learn more: https://drsue.ca/2025/08/obesity-canada-2025-pharmacotherapy-guidelines-what-couldnt-we-answer/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to gi...

Erectile dysfunction (ED) is common in men with elevated weight. Can weight loss medications improve ED? Learn more: https://drsue.ca/2025/08/can-weight-loss-medications-improve-erectile-dysfunction-ed/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own ph...

In choosing the best GLP1-based medication for our patients with type 2 diabetes at high risk of cardiovascular disease, guidelines recommend choosing one that has proven reduction in risk of CV events in cardiovascular outcome trials (CVOTs). High level results just released on Mounjaro's SURPASS CVOT study tell us how mounjaro stacks up. Read on to find out! Learn more: https://drsue.ca/2025/08/how-does-mounjaro-stack-up-for-cardiovascular-protection-the-surpass-cvot-results/ Any medical di...

Can creatine supplements preserve muscle during weight loss? Learn more: https://drsue.ca/2025/07/can-creatine-supplements-preserve-muscle-during-weight-loss/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your ow...

We often talk about sleep as a luxury in our busy lives. But what if we redefined sleep entirely? What if we thought of sleep like an essential vitamin – non-negotiable, restorative, and vital? It’s time we start seeing sleep as a nutrient. Learn more: https://drsue.ca/2025/07/sleep-is-a-nutrient/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, ...

As we gain 20+ years of experience with GLP1-based treatment, I continue to be fascinated by the diversity of potential benefits that we are finding in clinical trials and in clinical practice. A fascinating article was recently published reviewing the potential benefits of GLP1-based medication to skin conditions. Find out more here! Learn more: https://drsue.ca/2025/07/could-glp1-weight-loss-diabetes-medications-benefit-skin-conditions-like-psoriasis-or-hidradenitis-suppurativa/ Any m...